Intuitive Surgical, Inc. $ISRG Shares Acquired by Sierra Summit Advisors LLC

Sierra Summit Advisors LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,303 shares of the medical equipment provider’s stock after purchasing an additional 1,300 shares during the quarter. Intuitive Surgical comprises about 1.7% of Sierra Summit Advisors LLC’s portfolio, making the stock its 23rd biggest position. Sierra Summit Advisors LLC’s holdings in Intuitive Surgical were worth $10,869,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. SteelPeak Wealth LLC increased its position in shares of Intuitive Surgical by 28.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after acquiring an additional 9,364 shares during the period. Atlantic Union Bankshares Corp increased its holdings in shares of Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after purchasing an additional 3,676 shares during the period. World Investment Advisors raised its stake in shares of Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after purchasing an additional 3,803 shares during the last quarter. E. Ohman J or Asset Management AB lifted its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock worth $12,659,000 after purchasing an additional 1,123 shares during the period. Finally, Valley Wealth Managers Inc. boosted its position in Intuitive Surgical by 52.7% in the third quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after buying an additional 1,409 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the completion of the sale, the director directly owned 15,720 shares in the company, valued at approximately $8,355,494.40. The trade was a 15.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 56,409 shares of company stock valued at $30,895,377. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Citigroup restated a “neutral” rating and set a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Sanford C. Bernstein increased their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. UBS Group set a $570.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a report on Tuesday. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Trading Down 0.7%

Shares of ISRG stock opened at $503.51 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The business’s 50 day moving average is $529.83 and its two-hundred day moving average is $511.71. The company has a market capitalization of $178.81 billion, a P/E ratio of 63.82, a P/E/G ratio of 3.88 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the prior year, the company posted $2.21 EPS. The business’s quarterly revenue was up 18.8% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.